+2,218.9%
LRCX vs CVS
+57.5%
+2,161.4%
-57.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -3.1% | +3.1% | +0.8% |
| 7D | -5.3% | -3.6% | -1.7% | -4.3% |
| 30D | -20.2% | -6.4% | -13.7% | -19.0% |
| 3M | -38.7% | -8.1% | -30.6% | -37.6% |
| 6M | -25.9% | -9.3% | -16.6% | -24.7% |
| YTD | +23.4% | +11.4% | +12.0% | +16.6% |
| 1Y | +43.5% | +12.8% | +30.7% | +35.0% |
| 3Y | +208.4% | +39.6% | +168.8% | +158.5% |
| 5Y | +251.5% | +9.4% | +242.1% | +224.6% |
| 10Y | +2,218.9% | +57.7% | +2,161.3% | +1,597.5% |
| All | +2,218.9% | +57.5% | +2,161.4% | +1,597.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling